Commission Implementing Regulation (EU) 2018/524 of 28 March 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, clodinafop, clopyralid, cyprodinil, dichlorprop-P, fosetyl, mepanipyrim, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, quinoxyfen, rimsulfuron, spinosad, thiacloprid, thiamethoxam, thiram, tolclofos-methyl, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2018/524
• Articles: 3

Article 1

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 73, Thiram, the date is replaced by ‘30 April 2019’;

(2)

in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by ‘30 April 2019’;

(3)

in the sixth column, expiration of approval, of row 82, Quinoxyfen, the date is replaced by ‘30 April 2019’;

(4)

in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis Strain: MA 342, the date is replaced by ‘30 April 2019’;

(5)

in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by ‘30 April 2019’;

(6)

in the sixth column, expiration of approval, of row 92, Thiacloprid, the date is replaced by ‘30 April 2019’;

(7)

in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced by ‘30 April 2019’;

(8)

in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by ‘30 April 2019’;

(9)

in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘30 April 2019’;

(10)

in the sixth column, expiration of approval, of row 126, Tolclofos-methyl, the date is replaced by ‘30 April 2019’;

(11)

in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by ‘30 April 2019’;

(12)

in the sixth column, expiration of approval, of row 129, Clopyralid, the date is replaced by ‘30 April 2019’;

(13)

in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by ‘30 April 2019’;

(14)

in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by ‘30 April 2019’;

(15)

in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by ‘30 April 2019’;

(16)

in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by ‘30 April 2019’;

(17)

in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by ‘30 April 2019’;

(18)

in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 April 2019’;

(19)

in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by ‘30 April 2019’;

(20)

in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by ‘30 April 2019’;

(21)

in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, the date is replaced by ‘30 April 2019’;

(22)

in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by ‘30 April 2019’;

(23)

in the sixth column, expiration of approval, of row 140, Thiamethoxam, the date is replaced by ‘30 April 2019’.